Brian Hatch is an experienced Director of Bioproduct Research & Development at Eli Lilly, where they have focused on mammalian cell culture GMP and biopharmaceutical manufacturing since 2002. They have successfully led significant projects, including the design and qualification of a new GMP facility for gene therapy drug substances from 2021 to 2023, and contributed to the startup of commercial biopharmaceutical manufacturing facilities. Brian holds a BS in Biology and a BS in Microbiology from Kansas State University and previously worked as a Quality Control Microbiologist at Pfizer and in technical services at SAFC Biosciences/Sigma-Aldrich. Their extensive expertise encompasses process development, microbiological control, and the establishment of governing policies in the biopharmaceutical industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices